Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)
14/08/2023
Kim Lauper1, Denis Mongin 2, Sytske Anne Bergstra 3, Denis Choquette 4, Catalin Codreanu 5, Ori Elkayam 6, Kimme Hyrich 7, Florenzo Iannone 8, Eirik Kristianslund 9, Tore Kvien 10, Burkhard Leeb 11, Galina Lukina 12, Dan Nordström 13, Fatos Onen 14, Karel Pavelka 15, Manuel Pombo-Suarez 16, Ziga Rotar 17, Maria José Santos 18, Anja Strangfeld 19, Delphine Courvoisier 20 and Axel Finckh 20
ACR 2019
Lauper K, Mongin D, Bergstra S, Choquette D, Codreanu C, Elkayam O, Hyrich K, Iannone F, Kristianslund E, Kvien T, Leeb B, Lukina G, Nordström D, Onen F, Pavelka K, Pombo-Suarez M, Rotar Z, Santos M, Strangfeld A, Courvoisier D, Finckh A. Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/heterogeneity-in-the-pattern-of-use-of-jak-inhibitors-between-countries-participating-in-an-international-collaboration-of-registers-of-rheumatoid-arthritis-patients-the-jak-pot-study/
https://acrabstracts.org/abstract/heterogeneity-in-the-pattern-of-use-of-jak-inhibitors-between-countries-participating-in-an-international-collaboration-of-registers-of-rheumatoid-arthritis-patients-the-jak-pot-study/